Monopar Therapeutics, Inc. (MNPR)
70.65
-1.93
(-2.66%)
USD |
NASDAQ |
Oct 23, 16:00
71.89
+1.24
(+1.76%)
After-Hours: 20:00
Monopar Therapeutics Price to Book Value : 3.624 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 3.624 |
| October 22, 2026 | 3.723 |
| October 21, 2026 | 3.711 |
| October 20, 2026 | 3.808 |
| October 19, 2026 | 3.666 |
| October 16, 2026 | 3.553 |
| October 15, 2026 | 3.683 |
| October 14, 2026 | 3.750 |
| October 13, 2026 | 3.697 |
| October 12, 2026 | 3.952 |
| October 09, 2026 | 4.050 |
| October 08, 2026 | 4.308 |
| October 07, 2026 | 4.298 |
| October 06, 2026 | 4.082 |
| October 05, 2026 | 4.016 |
| October 02, 2026 | 4.000 |
| October 01, 2026 | 4.000 |
| September 30, 2026 | 4.087 |
| September 29, 2026 | 4.104 |
| September 28, 2026 | 4.294 |
| September 25, 2026 | 4.372 |
| September 24, 2026 | 4.557 |
| September 23, 2026 | 4.585 |
| September 22, 2026 | 4.957 |
| September 21, 2026 | 4.91 |
| Date | Value |
|---|---|
| September 18, 2026 | 4.948 |
| September 17, 2026 | 5.268 |
| September 16, 2026 | 5.204 |
| September 15, 2026 | 5.352 |
| September 14, 2026 | 5.556 |
| September 11, 2026 | 5.656 |
| September 10, 2026 | 5.640 |
| September 09, 2026 | 5.764 |
| September 08, 2026 | 5.867 |
| September 04, 2026 | 6.030 |
| September 03, 2026 | 6.081 |
| September 02, 2026 | 5.965 |
| September 01, 2026 | 6.031 |
| August 31, 2026 | 5.741 |
| August 28, 2026 | 5.739 |
| August 27, 2026 | 5.844 |
| August 26, 2026 | 5.833 |
| August 25, 2026 | 5.684 |
| August 24, 2026 | 5.712 |
| August 21, 2026 | 5.526 |
| August 20, 2026 | 5.688 |
| August 19, 2026 | 6.352 |
| August 18, 2026 | 6.107 |
| August 17, 2026 | 5.975 |
| August 14, 2026 | 5.798 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.32 |
| Anika Therapeutics, Inc. | 2.088 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.376 |
Price to Book Value Related Metrics
| Price | 70.65 |
| Earnings Yield | -3.31% |
| Market Cap | 474.22M |